Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus

•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant act...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavioural brain research 2018-01, Vol.337, p.131-138
Hauptverfasser: Khalili-Fomeshi, Mohsen, Azizi, Mohammad Golparvar, Esmaeili, Mohammad Reza, Gol, Mohammad, Kazemi, Sohrab, Ashrafpour, Manouchehr, Moghadamnia, Ali Akbar, Hosseinzadeh, Soheila
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 138
container_issue
container_start_page 131
container_title Behavioural brain research
container_volume 337
creator Khalili-Fomeshi, Mohsen
Azizi, Mohammad Golparvar
Esmaeili, Mohammad Reza
Gol, Mohammad
Kazemi, Sohrab
Ashrafpour, Manouchehr
Moghadamnia, Ali Akbar
Hosseinzadeh, Soheila
description •MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.
doi_str_mv 10.1016/j.bbr.2017.09.031
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1942700132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432817310938</els_id><sourcerecordid>1942700132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</originalsourceid><addsrcrecordid>eNp9kLtuFTEQhi1ERA6BB6BBLml28WVvhgpFXCJFCgXUli9zkjnatRfbGwEPkOeOwwmUNDPNN7_m_wh5xVnLGR_eHlprUysYH1umWib5E7Lj0yiase_UU7KrzNB0Ukyn5HnOB8ZYx3r-jJyKSUnVMbkjd19xhYQBaIJcYh00lwRrib9jiQ5Dg8FvDjx18TpgwVuguKwG0wKh5Hf0ImS8vimZYiiRxp_ozR_ImtkEV-FAHSSwKeYVg5npft7QUxM8vcF1jc4s65ZfkJO9mTO8fNxn5Punj9_OvzSXV58vzj9cNk72sjTDwL2ZnB-Ul8Lx0QrhOVNSWiWnnkNvlAXPnRim0dth7BSbautpMHzfWdPJM_LmmLum-GOrjfWC2cFcf4W4Zc1VJ0bGuBQV5UfU1ddzgr1eEy4m_dKc6Qf9-qCrfv2gXzOlq_568_oxfrML-H8Xf31X4P0RgFryFiHp7BCqJ48JXNE-4n_i7wG_H5jc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1942700132</pqid></control><display><type>article</type><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</creator><creatorcontrib>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</creatorcontrib><description>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2017.09.031</identifier><identifier>PMID: 28939403</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alkaloids - therapeutic use ; Alzheimer’s disease ; Analysis of Variance ; Animals ; Antibiotics, Antineoplastic - toxicity ; Avoidance Learning - drug effects ; Benzodioxoles - therapeutic use ; Cerebrospinal fluid ; Cognition Disorders - cerebrospinal fluid ; Cognition Disorders - chemically induced ; Cognition Disorders - drug therapy ; Cognition Disorders - pathology ; Cognitive impairment ; Cytochrome P-450 Enzyme Inhibitors - therapeutic use ; Dose-Response Relationship, Drug ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - pathology ; Lipid Peroxidation - drug effects ; Male ; Malondialdehyde - cerebrospinal fluid ; Maze Learning - drug effects ; Memantine - cerebrospinal fluid ; Memory, Short-Term - drug effects ; Neurons - drug effects ; Neurons - pathology ; Oxidative stress ; Piperidines - therapeutic use ; Piperine ; Polyunsaturated Alkamides - therapeutic use ; Rats ; Rats, Wistar ; Streptozocin - toxicity ; Streptozotocin</subject><ispartof>Behavioural brain research, 2018-01, Vol.337, p.131-138</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</citedby><cites>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbr.2017.09.031$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28939403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khalili-Fomeshi, Mohsen</creatorcontrib><creatorcontrib>Azizi, Mohammad Golparvar</creatorcontrib><creatorcontrib>Esmaeili, Mohammad Reza</creatorcontrib><creatorcontrib>Gol, Mohammad</creatorcontrib><creatorcontrib>Kazemi, Sohrab</creatorcontrib><creatorcontrib>Ashrafpour, Manouchehr</creatorcontrib><creatorcontrib>Moghadamnia, Ali Akbar</creatorcontrib><creatorcontrib>Hosseinzadeh, Soheila</creatorcontrib><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</description><subject>Alkaloids - therapeutic use</subject><subject>Alzheimer’s disease</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Avoidance Learning - drug effects</subject><subject>Benzodioxoles - therapeutic use</subject><subject>Cerebrospinal fluid</subject><subject>Cognition Disorders - cerebrospinal fluid</subject><subject>Cognition Disorders - chemically induced</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - pathology</subject><subject>Cognitive impairment</subject><subject>Cytochrome P-450 Enzyme Inhibitors - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Malondialdehyde - cerebrospinal fluid</subject><subject>Maze Learning - drug effects</subject><subject>Memantine - cerebrospinal fluid</subject><subject>Memory, Short-Term - drug effects</subject><subject>Neurons - drug effects</subject><subject>Neurons - pathology</subject><subject>Oxidative stress</subject><subject>Piperidines - therapeutic use</subject><subject>Piperine</subject><subject>Polyunsaturated Alkamides - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Streptozocin - toxicity</subject><subject>Streptozotocin</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtuFTEQhi1ERA6BB6BBLml28WVvhgpFXCJFCgXUli9zkjnatRfbGwEPkOeOwwmUNDPNN7_m_wh5xVnLGR_eHlprUysYH1umWib5E7Lj0yiase_UU7KrzNB0Ukyn5HnOB8ZYx3r-jJyKSUnVMbkjd19xhYQBaIJcYh00lwRrib9jiQ5Dg8FvDjx18TpgwVuguKwG0wKh5Hf0ImS8vimZYiiRxp_ozR_ImtkEV-FAHSSwKeYVg5npft7QUxM8vcF1jc4s65ZfkJO9mTO8fNxn5Punj9_OvzSXV58vzj9cNk72sjTDwL2ZnB-Ul8Lx0QrhOVNSWiWnnkNvlAXPnRim0dth7BSbautpMHzfWdPJM_LmmLum-GOrjfWC2cFcf4W4Zc1VJ0bGuBQV5UfU1ddzgr1eEy4m_dKc6Qf9-qCrfv2gXzOlq_568_oxfrML-H8Xf31X4P0RgFryFiHp7BCqJ48JXNE-4n_i7wG_H5jc</recordid><startdate>20180130</startdate><enddate>20180130</enddate><creator>Khalili-Fomeshi, Mohsen</creator><creator>Azizi, Mohammad Golparvar</creator><creator>Esmaeili, Mohammad Reza</creator><creator>Gol, Mohammad</creator><creator>Kazemi, Sohrab</creator><creator>Ashrafpour, Manouchehr</creator><creator>Moghadamnia, Ali Akbar</creator><creator>Hosseinzadeh, Soheila</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180130</creationdate><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><author>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alkaloids - therapeutic use</topic><topic>Alzheimer’s disease</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Avoidance Learning - drug effects</topic><topic>Benzodioxoles - therapeutic use</topic><topic>Cerebrospinal fluid</topic><topic>Cognition Disorders - cerebrospinal fluid</topic><topic>Cognition Disorders - chemically induced</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - pathology</topic><topic>Cognitive impairment</topic><topic>Cytochrome P-450 Enzyme Inhibitors - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Malondialdehyde - cerebrospinal fluid</topic><topic>Maze Learning - drug effects</topic><topic>Memantine - cerebrospinal fluid</topic><topic>Memory, Short-Term - drug effects</topic><topic>Neurons - drug effects</topic><topic>Neurons - pathology</topic><topic>Oxidative stress</topic><topic>Piperidines - therapeutic use</topic><topic>Piperine</topic><topic>Polyunsaturated Alkamides - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Streptozocin - toxicity</topic><topic>Streptozotocin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khalili-Fomeshi, Mohsen</creatorcontrib><creatorcontrib>Azizi, Mohammad Golparvar</creatorcontrib><creatorcontrib>Esmaeili, Mohammad Reza</creatorcontrib><creatorcontrib>Gol, Mohammad</creatorcontrib><creatorcontrib>Kazemi, Sohrab</creatorcontrib><creatorcontrib>Ashrafpour, Manouchehr</creatorcontrib><creatorcontrib>Moghadamnia, Ali Akbar</creatorcontrib><creatorcontrib>Hosseinzadeh, Soheila</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khalili-Fomeshi, Mohsen</au><au>Azizi, Mohammad Golparvar</au><au>Esmaeili, Mohammad Reza</au><au>Gol, Mohammad</au><au>Kazemi, Sohrab</au><au>Ashrafpour, Manouchehr</au><au>Moghadamnia, Ali Akbar</au><au>Hosseinzadeh, Soheila</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2018-01-30</date><risdate>2018</risdate><volume>337</volume><spage>131</spage><epage>138</epage><pages>131-138</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28939403</pmid><doi>10.1016/j.bbr.2017.09.031</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 2018-01, Vol.337, p.131-138
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_1942700132
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Alkaloids - therapeutic use
Alzheimer’s disease
Analysis of Variance
Animals
Antibiotics, Antineoplastic - toxicity
Avoidance Learning - drug effects
Benzodioxoles - therapeutic use
Cerebrospinal fluid
Cognition Disorders - cerebrospinal fluid
Cognition Disorders - chemically induced
Cognition Disorders - drug therapy
Cognition Disorders - pathology
Cognitive impairment
Cytochrome P-450 Enzyme Inhibitors - therapeutic use
Dose-Response Relationship, Drug
Hippocampus - drug effects
Hippocampus - metabolism
Hippocampus - pathology
Lipid Peroxidation - drug effects
Male
Malondialdehyde - cerebrospinal fluid
Maze Learning - drug effects
Memantine - cerebrospinal fluid
Memory, Short-Term - drug effects
Neurons - drug effects
Neurons - pathology
Oxidative stress
Piperidines - therapeutic use
Piperine
Polyunsaturated Alkamides - therapeutic use
Rats
Rats, Wistar
Streptozocin - toxicity
Streptozotocin
title Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Piperine%20restores%20streptozotocin-induced%20cognitive%20impairments:%20Insights%20into%20oxidative%20balance%20in%20cerebrospinal%20fluid%20and%20hippocampus&rft.jtitle=Behavioural%20brain%20research&rft.au=Khalili-Fomeshi,%20Mohsen&rft.date=2018-01-30&rft.volume=337&rft.spage=131&rft.epage=138&rft.pages=131-138&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2017.09.031&rft_dat=%3Cproquest_cross%3E1942700132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1942700132&rft_id=info:pmid/28939403&rft_els_id=S0166432817310938&rfr_iscdi=true